Skip to content

Serum lipidomics in patients with sarcoidosis before and after pulmonary rehabilitation

Serum lipidomics in patients with sarcoidosis before and after pulmonary rehabilitation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619001479190
Enrollment
14
Registered
2019-10-25
Start date
2015-11-17
Completion date
2017-11-30
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aimed to determine the use of lipid profiling to assess the effects of pulmonary rehabilitation on patients with sarcoidosis. Serum was collected from 14 patients with stage II sarcoidosis before and after pulmonary rehabilitation. Proton nuclear magnetic resonance (NMR) spectroscopy combined with orthogonal partial least squares-discriminant analysis (DA) was used. Twenty-five NMR signals from lipid compounds were selected for further analysis. The DA correctly classified the patients into groups in 96% of the cases before and after rehabilitation. Analysis of response to the rehabilitation indicated that fatty acids, plasminogen, and total cholesterol were the most involved. Multivariate DA yielded a list of potential biomarkers that were significantly higher in the patients after rehabilitation. This study presents a novel method that can be used to analyze the responses to pulmonary rehabilitation in patients with sarcoidosis.

Interventions

This study aimed to determine the use of lipid profiling to assess the effects of pulmonary rehabilitation on patients with sarcoidosis. Serum was collected from 14 patients with newly diagnosed II stage of sarcoidosis (up to 6 months, aged 34–63 years) before and after pulmonary rehabilitation in the Department of Lung Diseases and Tuberculosis between November 2015 and December 2017. Before and after pulmonary rehabilitation all patients had evaluated: - fatigue by Fatigue Assessment Scale

This study aimed to determine the use of lipid profiling to assess the effects of pulmonary rehabilitation on patients with sarcoidosis. Serum was collected from 14 patients with newly diagnosed II stage of sarcoidosis (up to 6 months, aged 34–63 years) before and after pulmonary rehabilitation in the Department of Lung Diseases and Tuberculosis between November 2015 and December 2017. Before and after pulmonary rehabilitation all patients had evaluated: - fatigue by Fatigue Assessment Scale (FAS) - the level of dyspnea by The Medical Research Council (MRC) questionnaire - forced vital capacity, forced expiratory volume during the first second, total lung capacity, and transfer factor for carbon monoxide (TLCO) - mobility by the 6-minute walk test (6MWT) - muscle strength: the maximal isometric grip strengths of the left and right hands by hydraulic hand dynamometer and expressed in kilograms (kg), respiratory muscle force by the maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). - blood analysis: serum glucose, urea, creatinine, total protein, C-reactive protein (CRP), angiotensin converting enzyme (ACE), total protein, total cholesterol (TCH), triglycerides (TG), low-density lipoprotein concentration (LDL-c), and high-density lipoprotein concentration (HDL-c), the markers of inflammation and cell damage (sICAM-1, TNF-a, and IL-6), myosin and myoglobin. Intervention Patients were encouraged to start a 3-week physical training program (5 days a week), which was supervised by a physical therapist and based on their physical performance assessed at baseline. The exercise program included three major components, namely, aerobic endurance training (stationary cycling or treadmill up to 30 min/day), inspiratory muscle training, and peripheral muscle strength training (three sets of 15–20 repetitions of five different exercises). The resistance level was individualized for each patient (in accordance with patient preference), reassessed, and adjusted after every session using the Borg Rating of Perceived Exertion. Inspiratory muscle training was introduced using the Threshold IMP (Healthdyne Technologies, Great Britain) and consisted of six courses of inspiratory exercises with five inspiratory maneuvers in each series and 1 min of rest between them. After completing the exercises, the subjects were required to cool down for 5 min. All exercise modalities were progressed regularly by an experienced exercise physiologist to maintain dyspnea Borg RPE score of 13-15. Pulse-oximetry was used to monitor peripheral oxygen saturation levels during exercises. Supplemental oxygen use during training was commensurate with current prescriptions. It was provided during training if SpO2 on room air was below 88% whilst exercising and was titrated to maintain a SpO2 above 90%. During exercises pulse was monitored continuously, and patients were encouraged to increase their effort to 70% of Pulse max according to the Karvelen’s formula.

Sponsors

Medical University of Silesia
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Serum was collected from 14 patients with newly diagnosed II stage of sarcoidosis (up to 6 months, aged 34–63 years) before and after pulmonary rehabilitation in the Department of Lung Diseases and Tuberculosis between November 2015 and December 2017. The patients were diagnosed based on consistent clinical features, bronchoalveolar lavage (BAL) fluid analysis, and/or biopsy-proven non-caseating epithelioid cell granulomas.

Exclusion criteria

- ischemic heart disease, congestive heart failure, severe pulmonary hypertension - substantial liver function impairments, diabetes - stroke in medical history - addictions: tobacco, drugs, alcohol - increased cognitive impairments in the form of dementia - neurological impairments or impairments of the locomotor system precluding the performance of the exercises - lack of consent and will to cooperate

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026